Agensys CEO to retire

TOKYO The president and CEO of Agensys, a subsidiary of Japanese drug maker Astellas, will retire, Astellas said Tuesday.


Donald Rice founded Agensys as UroGenesys in Santa Monica, Calif., in 1996 for the development of biotech drugs for treating cancer. Astellas acquired Agensys in December 2007.


Former Allergan SVP, head of global drug development and chief medical officer Sef Kurstjens will replace Rice as president and CEO of Agensys.

Login or Register to post a comment.